Newsroom
Sorted by: Latest
-
Incyte gibt positive Stellungnahme des CHMP zu Opzelura ® (Ruxolitinib)-Creme zur Behandlung von Erwachsenen mit mittelschwerer atopischer Dermatitis bekannt
MORGES, Schweiz--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) gab heute bekannt, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittelagentur (EMA) eine positive Stellungnahme abgegeben und die Zulassung von Opzelura® (Ruxolitinib)-Creme zur Behandlung von mittelschwerer atopischer Dermatitis (AD) bei erwachsenen Patienten, bei denen topische Kortikosteroide (TCS) und topische Calcineurin-Hemmer (TCI) unzureichend oder ungeeignet sind, empfohlen hat. „AD ist eine chronische Ha...
-
Samenvatting: Incyte kondigt positief CHMP-advies aan voor Opzelura® (ruxolitinib)-crème voor de behandeling van volwassenen met matige atopische dermatitis
MORGES, Zwitserland--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) heeft vandaag bekendgemaakt dat het Comité voor geneesmiddelen voor menselijk gebruik (CHMP) van het Europees Geneesmiddelenbureau (EMA) een positief advies heeft uitgebracht waarin wordt aanbevolen Opzelura® (ruxolitinib)-crème goed te keuren voor de behandeling van matige atopische dermatitis (AD) bij volwassen patiënten voor wie lokale corticosteroïden (TCS) en lokale calcineurineremmers (TCI) onvoldoende effectief of niet geschikt...
-
Riassunto: Incyte annuncia l'opinione positiva del CHMP per Opzelura® (ruxolitinib) crema per il trattamento della dermatite atopica moderata in pazienti adulti
MORGES, Svizzera--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) oggi ha annunciato che il Comitato per i prodotti medicinali per uso umano (CHMP) dell'Agenzia Europea per i Medicinali (EMA) ha espresso un'opinione positiva sul farmaco, raccomandando l'approvazione di Opzelura® (ruxolitinib) crema per il trattamento della dermatite atopica (DA) moderata in pazienti adulti per i quali i corticosteroidi topici (TCS) e gli inibitori topici della calcineurina (TCI) sono inadeguati o inadatti. Il testo orig...
-
Resumen: Incyte anuncia un dictamen favorable del CHMP sobre la crema Opzelura® (ruxolitinib) para tratar a los pacientes adultos con dermatitis atópica moderada
MORGES, Suiza--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) ha anunciado hoy que el Comité de Medicamentos de Uso Humano (Committee for Medicinal Products for Human Use, CHMP) de la Agencia Europea de Medicamentos (EMA) ha emitido un dictamen favorable en el que recomienda la autorización de la crema Opzelura® (ruxolitinib) para tratar la dermatitis atópica (DA) moderada en los pacientes adultos para quienes los corticosteroides tópicos (CT) y los inhibidores tópicos de la calcineurina (ITC) resultan...
-
KBRA Comments on Colony Bancorp, Inc.'s Proposed Merger with First Reliance Bancshares, Inc.
NEW YORK--(BUSINESS WIRE)--On June 24, 2026, Fitzgerald, GA-based Colony Bancorp, Inc. (NYSE: CBAN) (“Colony”), parent company of Colony Bank, and Florence, SC-based First Reliance Bancshares, Inc. (OTCQX: FSRL) (“First Reliance”), parent company of First Reliance Bank, jointly announced that they had entered into a definitive merger agreement pursuant to which First Reliance Bancshares, Inc. would merger with and into Colony Bancorp, Inc., and First Reliance Bank would merger with and into Col...
-
Tractor Supply and 4-H Collaborate With Starlink to Bridge the Digital Divide in Rural Communities
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States; Starlink, the world’s most advanced satellite constellation that delivers reliable broadband connectivity nationwide, including to locations where high-speed internet has traditionally been too expensive, unreliable or entirely unavailable; and 4-H, America’s largest youth development organization, announced today an alliance aimed at expanding broadband access in...
-
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software
ATLANTA--(BUSINESS WIRE)--VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where...
-
AM Best Afirma Calificaciones Crediticias de Liberty Colombia Compañía Seguros S.A.
CIUDAD DE MÉXICO--(BUSINESS WIRE)--AM Best ha afirmado la Calificación de Fortaleza Financiera, (FSR, por sus siglas en inglés) de A- (Excelente) y la Calificación Crediticia de Emisor (ICR, por sus siglas en inglés) de Largo Plazo de “a-” (Excelente) a Liberty Colombia Compañía Seguros S.A. (LCC) (Colombia). La perspectiva de estas Calificaciones Crediticias (calificaciones) es estable. Las calificaciones de LCC reflejan la fortaleza de su balance, la cual AM Best evalúa como fuerte, así como...
-
AM Best Affirms Credit Ratings of Liberty Mutual Surety Brasil Seguros S.A.
MEXICO CITY--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Liberty Mutual Surety Brasil Seguros S.A. (LMSB) (São Paulo, Brazil). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect LMSB’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM). The...
-
AM Best Affirms Credit Ratings of Liberty Colombia Compañía Seguros SA.
MEXICO CITY--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) to Liberty Colombia Compañía Seguros SA (LCC) (Colombia). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect LCC’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM). The ratings also con...